FREMONT, Calif., Cordis Corporation announced today the launch of the new ELITECROSS™ Support Catheter in the United States and OUTBACK ® Elite Re-Entry Catheter in the United States, Europe and Japan ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cordis Corporation, a worldwide leader in the development of interventional vascular technology, today announced it has completed the acquisition of Flexible ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation has entered into a distribution agreement with Ostial Solutions for the worldwide distribution of the OSTIAL PRO Stent Positioning System™. The ...
Cordis Corp., one of the most powerful players in coronary stents and the first to bring a drug-eluting stent to market is getting out of the business. The Johnson & Johnson (NYSE:JNJ) subsidiary, ...
BRIDGEWATER, N.J., June 15, 2011 /PRNewswire-FirstCall/ -- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular ...
Cordis Corporation has completed the acquisition of Flexible Stenting Solutions, a developer of flexible peripheral arterial, venous and biliary stents. Terms of the acquisition were not disclosed.
Company to Focus on Areas of Significant Patient Need in Cardiovascular Disease BRIDGEWATER, N.J., Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results